RGNX - Regenxbio - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

540.7M

Cash

338.7M

Avg Qtr Burn

-48.24M

Short % of Float

11.82%

Insider Ownership

7.32%

Institutional Own.

91.18%

Qtr Updated

03/31/24

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
RGX-121 Details Mucopolysaccharidosis type II, Rare diseases, Pulmonary arterial hypertension, Lung disease, Rare genetic disease, Genetic disorder, Mucopolysaccharidoses	BLA Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ABBV-RGX-314 (Subretinal Delivery) Details Eye disease , Wet age-related macular degeneration , Age-related macular degeneration	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ABBV-RGX-314 (Suprachoroidal Delivery) Details Eye disease , Diabetic retinopathy , Diabetes	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ABBV-RGX-314 (Suprachoroidal Delivery) Details Eye disease , Wet age-related macular degeneration , Age-related macular degeneration	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RGX-202 Details Rare diseases, Genetic disorder, Rare genetic disease, Duchenne muscular dystrophy	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RGX-381 Details Central nervous system illness	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RGX-111 Details Mucopolysaccharidoses, Rare genetic disease, Genetic disorder, Rare diseases, Mucopolysaccharidosis Type 1	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RGX-181 Details Central nervous system illness, Batten Disease	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.